Pu F R, Cheng S W, Zhu D
Third Teaching Hospital, Bethune University of Medical Sciences, Changchun.
Zhonghua Fu Chan Ke Za Zhi. 1994 Aug;29(8):478-80, 511.
In 31 patients with ovarian cancer, the sIL-2R level of the sera and ascitic fluids were measured by ELISA, to investigate the inhibitive effect of sIL-2R purified from ascitic fluids on normal lymphocyte transformation, stimulated with phytohemagglutinin (PHA). The results showed that the sera sIL-2R levels in the patients were much higher than those in the normal controls (857 +/- 428kU/L vs 235 +/- 90kU/L, P < 0.001). The sera sIL-2R levels in mucinous cancer were significantly higher than those in serous cancer (988 +/- 539kU/L vs 488 +/- 233kU/L P < 0.01). But no obvious correlation was observed with the histopathological grading, nor with metastasis. Higher levels of sIL-2R were also observed in the ascitic. The normal lymphocyte transformation stimulated with PHA was significantly inhibited by high sIL-2R purified from the ascitic fluids.
对31例卵巢癌患者,采用酶联免疫吸附测定法(ELISA)检测血清和腹水的可溶性白细胞介素2受体(sIL-2R)水平,以研究从腹水中纯化的sIL-2R对经植物血凝素(PHA)刺激的正常淋巴细胞转化的抑制作用。结果显示,患者血清sIL-2R水平显著高于正常对照(857±428kU/L对235±90kU/L,P<0.001)。黏液性癌患者血清sIL-2R水平显著高于浆液性癌患者(988±539kU/L对488±233kU/L,P<0.01)。但sIL-2R水平与组织病理学分级及转移均无明显相关性。腹水中也观察到较高水平的sIL-2R。从腹水中纯化的高浓度sIL-2R可显著抑制经PHA刺激的正常淋巴细胞转化。